RELMADA THERAPEUTICS, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $15.1M | $223.3M | $44.4M |
| FY2022 | $12.5M | $152.9M | $5.4M |
| FY2023 | $12.2M | $97.6M | $4.1M |
| FY2024 | $10.3M | $45.8M | $3.9M |
| FY2025 | $7.5M | $94.0M | $3.5M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $15.1M | $223.3M | $44.4M |
| FY2022 | $12.5M | $152.9M | $5.4M |
| FY2023 | $12.2M | $97.6M | $4.1M |
| FY2024 | $10.3M | $45.8M | $3.9M |
| FY2025 | $7.5M | $94.0M | $3.5M |